CALGARY, Alberta, April 29, 2026 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSX: CEMX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company“) a specialty construction contractor and leading supplier of cellular concrete in North America announced the release of its consolidated financial results for the first quarter ended March 31, 2026. “We achieved mixed results in our first quarter this year. We increased revenue but delivered lower margins. Our first quarter revenues were $7.3 million versus $6.6 million last year (a 11% increase). Our gross margins were 9% compared to 22% last year. The drop in gross margins compared to last year was due to our project mix with more larger projects this year compared to 2025. This drop in gross margins for the quarter impacted our financial performance on our key performance metrics...

Consolidated Sales of $157.6 million, down 1% excluding foreign exchange Net Income of $5.8 million and EBITDA of $18.0 million; Earnings per Share of $0.15, including $0.06 per share in restructuring charges; Free Cash Flow of $5.9 million compared with $3.1 million the prior year quarter; Automotive Solutions sales increased 5%, excluding foreign exchange supported by new program launches; Closure of the Large Mould Mexico facility is expected to support improved profitability in future periods; Quarterly dividend of $0.105 per common share to be paid June 30, 2026.TORONTO, April 29, 2026 (GLOBE NEWSWIRE) — Exco Technologies Limited (TSX-XTC) today announced results for its second quarter of fiscal 2026 ended March 31, 2026. In addition, Exco announced a quarterly dividend of $0.105 per common share which will be paid on June...

GREELEY, Colo., April 29, 2026 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC), one of the world’s leading food companies, reports its first quarter 2026 financial results. First Quarter HighlightsNet Sales of $4.5 billion. Consolidated GAAP Operating Income margin of 3.6%. GAAP Net Income of $101.5 million and GAAP EPS of $0.43. Adjusted Net Income of $121.7 million, and Adjusted EPS of $0.51. Adjusted EBITDA of $308.1 million, or a 6.8% margin, with Adjusted EBITDA margins of 7.0% in the U.S., 7.8% in Europe, and 3.1% in Mexico. The U.S. Fresh business implemented several projects during the quarter to upgrade product mix and enhance operational efficiencies in Big Bird, while growing Key Customer partnerships. Together, these projects will reinforce the foundation of future growth while reducing portfolio...

WILLIAMSVILLE, N.Y., April 29, 2026 (GLOBE NEWSWIRE) — National Fuel Gas Company (“National Fuel” or the “Company”) (NYSE:NFG) today announced consolidated results for the second quarter of its 2026 fiscal year. SECOND QUARTER FISCAL 2026 SUMMARYGAAP earnings of $247.7 million, or earnings per share (EPS) of $2.59, compared to GAAP earnings of $216.4 million, or $2.37 per share, in the prior year. Adjusted EPS of $2.71, an increase of 13% from the prior year. See non-GAAP reconciliation on page 2. Net cash provided by operating activities of $657 million, with free cash flow of $160 million (as defined on page 22) through the second quarter year-to-date, a $111 million increase from the prior year. Integrated Upstream and Gathering segment adjusted EPS of $1.67, an increase of 21% compared to the prior year, driven by a 17% increase...

Net Income of $46.2 million, EPS of $0.55 Operating Earnings of $58.4 million, Operating EPS of $0.70 Quarterly Dividend of $0.3225 Board Authorized $50 million Stock Buyback Program BOSTON, April 29, 2026 (GLOBE NEWSWIRE) — Beacon Financial Corporation (NYSE: BBT) (the “Company”) today announced net income of $46.2 million, or $0.55 per basic and diluted share, for the first quarter of 2026, compared to $53.4 million, or $0.64 per basic and diluted share, for the fourth quarter of 2025, and $19.1 million, or $0.21 per basic and diluted share, for the first quarter of 2025. “The first quarter results reflect near-term pressures and the tail end of merger activity as we completed the core system conversion in February,” stated Paul Perrault, the Company’s President and Chief Executive Officer. “We remain focused...

Provides Q2-26 Sales and Gross Margin Guidance WEST ORANGE, N.J., April 29, 2026 (GLOBE NEWSWIRE) — Bel Fuse Inc. (Nasdaq: BELFA and BELFB) today announced preliminary financial results for the first quarter of 2026. First Quarter 2026 Highlights• Net sales of $178.5 million compared to $152.2 million in Q1-25. Up 17.2% from Q1-25• Gross profit margin of 39.0%, up from 38.6% in Q1-25• GAAP net earnings attributable to Bel shareholders of $11.4 million in Q1-26, compared to net earnings of $17.9 million in Q1-25. Non-GAAP net earnings attributable to Bel shareholders of $22.8 million in Q1-26, versus $16.8 million in Q1-25• Adjusted EBITDA of $34.5 million (19.3% of sales), compared to $30.9 million (20.3% of sales) in Q1-25• Closed on acquisition of dataMate in March 2026• Realigned business units to enhance go-to-market...

NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) — FTAI Aviation Ltd. (NASDAQ: FTAI) (the “Company” or “FTAI”) today reported financial results for the first quarter 2026. The Company’s consolidated comparative financial statements and key performance measures are attached as an exhibit to this press release. Financial Overview(in thousands, except per share data)      Selected Financial Results   Q1’26  Net Income Attributable to Shareholders   $ 134,190  Basic Earnings per Ordinary Share   $ 1.31  Diluted Earnings per Ordinary Share   $ 1.29  Adjusted EBITDA (1)   $ 325,577         (1) For definitions and reconciliations of non-GAAP measures, please refer to the exhibit to this press release.     First Quarter 2026 Dividends On April 28, 2026, the Company’s Board of Directors (the “Board”) declared a cash...

First Quarter ResultsTotal revenues of $45.6 million, compared to $50.0 million in the same quarter of 2025  Net loss of $(0.4) million and loss per share of $(0.14), compared to net income of $4.1 million and diluted earnings per share of $1.51 in the same quarter of 2025 Adjusted EBITDA of $5.6 million, compared to $8.2 million in the same quarter of 2025 Cash flows from operating activities of $1.3 million and free cash flow of $0.7 million, increases compared to $(1.6) million and $(2.1) million, respectively, in the first quarter of 2025. $34.5 million in cash and $7.2 million of total debt as of March 31, 2026HOUSTON, April 29, 2026 (GLOBE NEWSWIRE) — NCS Multistage Holdings, Inc. (Nasdaq: NCSM) (the “Company,” “NCS,” “we” or “us”), a leading provider of highly engineered products and support services that facilitate the...

TRAVERSE CITY, Mich., April 29, 2026 (GLOBE NEWSWIRE) — MachTen, Inc. (OTC: MACT) today announced financial results for the full year ended December 31, 2025 and the first quarter of 2026. “2025 was another year of significant investment across infrastructure, systems, and the people necessary to transform Michigan Broadband into the leading regional provider of broadband communications,” said Dan Miller, Chief Executive Officer. “Since the spin-off in August 2023, we have systematically addressed the operational and structural challenges embedded in the legacy business and now have a clear path toward accelerating profitability. Cash flow is expected to materially improve in 2026, attributable to subscriber growth, a $3.1 million increase in annual Enhanced ACAM support, and a shift in broadband construction toward reimbursable...

ASCEND Phase 1/2 global clinical trial ongoing, evaluating CR-001, a PD-1 x VEGF bispecific antibody, in multiple solid tumor types in first-line and previously treated patients; first ADC combination trial with CR-001 on track to initiate in second half of 2026 Phase 1/2 trial of CR-003, an ITGB6-targeted ADC, ongoing in China CR-002, a PD-L1-targeted ADC, on track to enter the clinic in second half of 2026 Multiple key clinical data readouts anticipated beginning in Q1 2027 WALTHAM, Mass., April 29, 2026 (GLOBE NEWSWIRE) — Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced financial results for the first quarter ended March 31, 2026 and recent business highlights. “Crescent’s...